These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12433351)

  • 1. [Macrolide consumption according to geographic areas in the province of Valladolid].
    Pastor E; Eiros JM; Mayo A
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):498-502. PubMed ID: 12433351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of population structure on systemic antibiotic consumption. Valladolid, Spain].
    Enrique PG; Eiros Bouza JM; Mayo Iscar A
    Rev Esp Salud Publica; 2002; 76(4):293-300. PubMed ID: 12216169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
    De Rosa R; Avolio M; Stano P; Modolo ML; Camporese A
    Infez Med; 2009 Jun; 17(2):82-7. PubMed ID: 19602920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of population structure on the consumption of systemic antibiotics.
    Pastor García E; Eiros Bouza JM; Mayo Iscar A; Bachiller R
    Int J Antimicrob Agents; 2005 Jan; 25(1):84-8. PubMed ID: 15620831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).
    Glass SK; Pearl DL; McEwen SA; Finley R
    J Antimicrob Chemother; 2010 Jan; 65(1):148-55. PubMed ID: 19864333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study of cardioprotective and endothelioprotective action of macrolides and azalides].
    Chernomortseva ES; Pokrovskiĭ MV; Pokrovskaia TG; Artiushkova EB; Gureev VV
    Eksp Klin Farmakol; 2009; 72(2):29-31. PubMed ID: 19441724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
    Veber B; Pocidalo JJ
    Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A trial of the use of rulid, sumamed and makropen in the combined treatment of generalized periodontitis at a stage of exacerbation].
    Tsarev VN; Dmitrieva LA; Filatova NA; Romanov AE; Chekhova NO
    Stomatologiia (Mosk); 1997; 76(5):4-8. PubMed ID: 9411932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans.
    Samonis G; Maraki S; Anatoliotakis N; Anatoliotaki M; Apostolakou H; Margioris AN; Tselentis Y; Kontoyiannis DP
    Med Mycol; 2002 Apr; 40(2):139-42. PubMed ID: 12058726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allergy to macrolide antibiotics. Review of the literature].
    Demoly P; Benahmed S; Valembois M; Sahla H; Messaad D; Godard P; Michel FB; Bousquet J
    Presse Med; 2000 Feb; 29(6):321-6. PubMed ID: 10719452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
    Gelber RH; Siu P; Tsang M; Murray LP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z; Rosenberg S; Dan M
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T; Suzaki H
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.